OBJECTIVES: This systematic review aims to identify and critique full economic evaluations (EEs) of childhood asthma treatments with the intention to guide researchers and commissioners of paediatric asthma services towards potentially cost-effective strategies.
METHODS: 'MEDLINE', 'Embase', 'Econlit', 'NHS EED', and 'CEA' databases were searched to identify relevant EEs published between 2005 and May 2017. Quality of included studies was assessed with a published checklist.
RESULTS: Eighteen studies were identified and comprised one cost-benefit analysis, 11 cost-effectiveness analyses, one cost-minimisation analysis, and six cost-utility analyses. Treatments included pharmaceutical (n=11) and non-pharmaceutical (n=7) interventions. Fourteen studies identified cost-effective strategies. The quality of the studies varied and there were uncertainties due to the methods and relevance of data used.
CONCLUSION: Good quality economic evaluation studies of paediatric asthma treatments are lacking. EE of new technologies adapted to local settings is recommended and can result in cost-savings.